Related Experiment Video
Updated: Jun 8, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
[Neoplasic vena cava syndrome]
Leila El Fekih1, Leila Boussoffara, Sorraya Fenniche
1Service Ibn Nafiss, Hôpital Abderrahmen Mami Ariana.
Bronchopulmonary cancer frequently causes superior vena cava (SVC) syndrome, a blockage of the SVC. Treatment for this condition is well-established and involves managing both symptoms and the underlying lung cancer.
Area of Science:
- Oncology
- Pulmonology
- Vascular Medicine
Context:
- Superior vena cava (SVC) syndrome is often caused by extrinsic compression or thrombosis.
- Bronchopulmonary cancer is the most common etiological factor for SVC syndrome.
Purpose:
- To characterize the clinical, radiological, and treatment profiles of neoplastic SVC syndrome.
- To analyze treatment modalities for SVC syndrome secondary to lung cancer, irrespective of histological type.
Summary:
- A retrospective study of 20 male patients with SVC syndrome complicating primary bronchopulmonary cancer was conducted.
- Small cell lung cancer was the most frequent histological type; SVC syndrome revealed the cancer in 60% of cases.
- Treatment involved symptomatic management and etiological treatment for the underlying lung cancer.
Impact:
- Highlights bronchopulmonary cancer as the primary cause of SVC syndrome.
- Confirms that treatment protocols for neoplastic SVC syndrome are well-defined.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Portal Hypertension
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction

